Aditya Mahadevan

12PUBLICATIONS
21CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCancer geneticsSocial epidemiology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 22, 2026
Comparative Risk of Cardiovascular Hospitalization With Immune Checkpoint Inhibitors Versus Chemotherapy.

|Feb 06, 2026
Triple Negative Breast Cancer With Choroidal Metastasis Responsive to Sacituzumab Govitecan and Radiation Therapy.

Nellie Nafissi, Aditya Mahadevan, Elaine Chiao

|Jan 03, 2026
GLP-1 receptor agonists in patients with cancer are associated with reduced all-cause mortality and hospitalization.

Aditya Mahadevan, Aidan Vosooghi, Jagmeet S Arora

|Nov 04, 2025
Adequate Catchment Area Representation in Cancer Clinical Trials at NCI Designated Cancer Centers: The University of California Irvine Experience.

Frank Lee, Aditya Mahadevan, Armon Azizi

|Jul 18, 2025
Ethnic Demographic Shifts and the Rise in Early-Onset Esophageal, Gastric, and Colorectal Malignancies in the United States.

Elaine Chiao, Tevan Luong, Aditya Mahadevan

|Apr 29, 2025
Associations Between Pre-Existing Cardiovascular Disease and Survival in Patients on Immune Checkpoint Inhibitor Therapy.

Aditya Mahadevan, Aidan Vosooghi, Jagmeet Arora

Pageof 2

Frequent Collaborators

5 joint publications

Farshid Dayyani

2 joint publications

Elaine Chiao

2 joint publications

Jagmeet Arora

2 joint publications

Aidan Vosooghi